#CTOR #CTXR Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-october-2026-investor-xzz7y6pxek8x.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-october-2026-investor-xzz7y6pxek8x.html?utm_source=stocktitan-bluesky&utm_medium=social
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Citius Pharmaceuticals (CTXR) will participate in two New York City investor conferences, with Chairman and CEO Leonard Mazur presenting and hosting investor meetings. The Maxim Growth Summit runs October 12–14, 2026; the ThinkEquity Conference is October 15, with a presentation scheduled for 3:00–3:30 p.m. ET, subject to change. Mazur will discuss recent developments, including ongoing LYMPHIR commercialization by majority-owned Citius Oncology (CTOR).
www.stocktitan.net
October 12, 2026 at 12:30 PM
#CTOR #CTXR Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-october-2026-investor-xzz7y6pxek8x.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-october-2026-investor-xzz7y6pxek8x.html?utm_source=stocktitan-bluesky&utm_medium=social
$CTXR announced a productive Type C meeting with the #FDA following the successful Phase 3 trial of Mino-Lok for catheter-related bloodstream infections, receiving clear guidance on the pathway for a future NDA submission.
#biotech #stocks
www.biopharmcatalyst.com/company/CTXR...
#biotech #stocks
www.biopharmcatalyst.com/company/CTXR...
Biotech catalyst calendars and drug pipelines • BioPharmCatalyst
Profit on the stock market by investing in biotech stocks
www.biopharmcatalyst.com
November 25, 2024 at 1:30 PM
$CTXR announced a productive Type C meeting with the #FDA following the successful Phase 3 trial of Mino-Lok for catheter-related bloodstream infections, receiving clear guidance on the pathway for a future NDA submission.
#biotech #stocks
www.biopharmcatalyst.com/company/CTXR...
#biotech #stocks
www.biopharmcatalyst.com/company/CTXR...
I've tweaked more stuff.
Environment maps are now actually applied as reflections instead of affecting the 'Metallic' parameter. Truer to the PS2 look.
If models are imported using the CTXR files, the Alpha input will remain disconnected unless the texture name contains "alp_ovl" in the name.
Environment maps are now actually applied as reflections instead of affecting the 'Metallic' parameter. Truer to the PS2 look.
If models are imported using the CTXR files, the Alpha input will remain disconnected unless the texture name contains "alp_ovl" in the name.
August 25, 2025 at 4:36 AM
I've tweaked more stuff.
Environment maps are now actually applied as reflections instead of affecting the 'Metallic' parameter. Truer to the PS2 look.
If models are imported using the CTXR files, the Alpha input will remain disconnected unless the texture name contains "alp_ovl" in the name.
Environment maps are now actually applied as reflections instead of affecting the 'Metallic' parameter. Truer to the PS2 look.
If models are imported using the CTXR files, the Alpha input will remain disconnected unless the texture name contains "alp_ovl" in the name.
revokk.bandcamp.com/yum
codes:
3jqd-jcv3
59rs-kwgs
btlc-y4rl
dupq-bqcj
s59f-wzsy
prtx-ctxr
uqlj-562d
xgc8-bgxh
4kh2-wum5
4new-xp9r
qd64-jrgl
bhy4-ydfj
wcuj-blek
epw6-wj28
87st-cgwn
tw42-x3le
2ppw-jwv3
h9ln-h4bq
h3sm-vasz
qxq7-62cg
948x-yh43
zsus-7j5s
3jwp-5k2d
wghg-byxh
ctcn-cfm5
snjl-xa9r
pwgh-j2gl
codes:
3jqd-jcv3
59rs-kwgs
btlc-y4rl
dupq-bqcj
s59f-wzsy
prtx-ctxr
uqlj-562d
xgc8-bgxh
4kh2-wum5
4new-xp9r
qd64-jrgl
bhy4-ydfj
wcuj-blek
epw6-wj28
87st-cgwn
tw42-x3le
2ppw-jwv3
h9ln-h4bq
h3sm-vasz
qxq7-62cg
948x-yh43
zsus-7j5s
3jwp-5k2d
wghg-byxh
ctcn-cfm5
snjl-xa9r
pwgh-j2gl
Revok
revokk.bandcamp.com
March 14, 2026 at 12:07 PM
revokk.bandcamp.com/yum
codes:
3jqd-jcv3
59rs-kwgs
btlc-y4rl
dupq-bqcj
s59f-wzsy
prtx-ctxr
uqlj-562d
xgc8-bgxh
4kh2-wum5
4new-xp9r
qd64-jrgl
bhy4-ydfj
wcuj-blek
epw6-wj28
87st-cgwn
tw42-x3le
2ppw-jwv3
h9ln-h4bq
h3sm-vasz
qxq7-62cg
948x-yh43
zsus-7j5s
3jwp-5k2d
wghg-byxh
ctcn-cfm5
snjl-xa9r
pwgh-j2gl
codes:
3jqd-jcv3
59rs-kwgs
btlc-y4rl
dupq-bqcj
s59f-wzsy
prtx-ctxr
uqlj-562d
xgc8-bgxh
4kh2-wum5
4new-xp9r
qd64-jrgl
bhy4-ydfj
wcuj-blek
epw6-wj28
87st-cgwn
tw42-x3le
2ppw-jwv3
h9ln-h4bq
h3sm-vasz
qxq7-62cg
948x-yh43
zsus-7j5s
3jwp-5k2d
wghg-byxh
ctcn-cfm5
snjl-xa9r
pwgh-j2gl
I am still working hard on the cameraless direct address to camera 😊
The film is progressing and I have made 99 images so far.
Each image is an experiment in itself — photo/chemi-gram on paper. www.instagram.com/p/DbTW4-CtxR...
The film is progressing and I have made 99 images so far.
Each image is an experiment in itself — photo/chemi-gram on paper. www.instagram.com/p/DbTW4-CtxR...
July 27, 2026 at 7:11 PM
I am still working hard on the cameraless direct address to camera 😊
The film is progressing and I have made 99 images so far.
Each image is an experiment in itself — photo/chemi-gram on paper. www.instagram.com/p/DbTW4-CtxR...
The film is progressing and I have made 99 images so far.
Each image is an experiment in itself — photo/chemi-gram on paper. www.instagram.com/p/DbTW4-CtxR...
$SAVA reported that topline data from its Phase 3 ReThink-ALZ study of simufilam for Alzheimer’s disease failed to meet all endpoints
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2024/ca...
$CTXR $BBIO $CGTX $ALUR $ONCT $ELAB $CMAX $DRRX $RNAZ $EYEN
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2024/ca...
$CTXR $BBIO $CGTX $ALUR $ONCT $ELAB $CMAX $DRRX $RNAZ $EYEN
Biotech catalyst calendars and drug pipelines • BioPharmCatalyst
Profit on the stock market by investing in biotech stocks
www.biopharmcatalyst.com
November 25, 2024 at 1:32 PM
$SAVA reported that topline data from its Phase 3 ReThink-ALZ study of simufilam for Alzheimer’s disease failed to meet all endpoints
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2024/ca...
$CTXR $BBIO $CGTX $ALUR $ONCT $ELAB $CMAX $DRRX $RNAZ $EYEN
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2024/ca...
$CTXR $BBIO $CGTX $ALUR $ONCT $ELAB $CMAX $DRRX $RNAZ $EYEN
NEWS: ( NASDAQ: #CTXR ) Biotech/Pharma Stocks to Watch Citius Pharmaceuticals, Soligenix, Takeda, Pfizer
#StockMarket #News
#StockMarket #News
July 18, 2024 at 4:35 PM
Oh yeah, i got into the CTXR textures but i couldn't find them, i'll most likely just use Bee shaped blobs
April 26, 2025 at 3:41 PM
Oh yeah, i got into the CTXR textures but i couldn't find them, i'll most likely just use Bee shaped blobs
Just In: ( NASDAQ: #CTXR ) Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
#StockMarket #News
#StockMarket #News
July 18, 2024 at 4:25 PM
Just In: ( NASDAQ: #CTXR ) Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
#StockMarket #News
#StockMarket #News
The new CTXR files are simply repackaged DDS textures and there are tools to batch-dump them.
There's lots of info on CTXR because texture-swap mods are the first thing everyone looked into when the MC launched.
Support for the new CMDL is incomplete so I just ignore them.
There's lots of info on CTXR because texture-swap mods are the first thing everyone looked into when the MC launched.
Support for the new CMDL is incomplete so I just ignore them.
February 4, 2025 at 6:47 PM
The new CTXR files are simply repackaged DDS textures and there are tools to batch-dump them.
There's lots of info on CTXR because texture-swap mods are the first thing everyone looked into when the MC launched.
Support for the new CMDL is incomplete so I just ignore them.
There's lots of info on CTXR because texture-swap mods are the first thing everyone looked into when the MC launched.
Support for the new CMDL is incomplete so I just ignore them.
4 - [very manual, includes MGS3] Still use Noesis for the models. But then, extract the CTXR (they're also DDS) textures from the MC and match them manually.
January 12, 2025 at 4:01 PM
4 - [very manual, includes MGS3] Still use Noesis for the models. But then, extract the CTXR (they're also DDS) textures from the MC and match them manually.
🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.
AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CTXR, #JMIA, #HOOD, #ONON, #SRAD
#OptionFlow #OptionsTrading #Trading
AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CTXR, #JMIA, #HOOD, #ONON, #SRAD
#OptionFlow #OptionsTrading #Trading
August 6, 2024 at 6:47 PM
🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.
AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CTXR, #JMIA, #HOOD, #ONON, #SRAD
#OptionFlow #OptionsTrading #Trading
AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CTXR, #JMIA, #HOOD, #ONON, #SRAD
#OptionFlow #OptionsTrading #Trading
NEWS: ( NASDAQ: #CTXR ) Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA ) and LYMPHIR(TM) in Cancer Patients with Recurrent Solid Tumors
#StockMarket #News
#StockMarket #News
November 11, 2024 at 5:25 PM
I dunno how much it can help your projects, and I dunno how much interest there is in making mods with it, but yeah, I'm very happy with the progress!
Some kind folks have also put together a lookup of ctxr IDs to tri IDs based on the resource manifests, fwiw. There's a copy in the SeaLouse repo.
Some kind folks have also put together a lookup of ctxr IDs to tri IDs based on the resource manifests, fwiw. There's a copy in the SeaLouse repo.
August 16, 2025 at 2:47 PM
I dunno how much it can help your projects, and I dunno how much interest there is in making mods with it, but yeah, I'm very happy with the progress!
Some kind folks have also put together a lookup of ctxr IDs to tri IDs based on the resource manifests, fwiw. There's a copy in the SeaLouse repo.
Some kind folks have also put together a lookup of ctxr IDs to tri IDs based on the resource manifests, fwiw. There's a copy in the SeaLouse repo.
It's confusing, but the MC games feature the whole collection of PS2 assets pretty much untouched (KMS,EVM, TRI) but they also add a second directory where you can find the updated textures (CMDL, CTXR).
So the new version of the plugin still works with the old files, not the new ones.
So the new version of the plugin still works with the old files, not the new ones.
February 4, 2025 at 6:45 PM
It's confusing, but the MC games feature the whole collection of PS2 assets pretty much untouched (KMS,EVM, TRI) but they also add a second directory where you can find the updated textures (CMDL, CTXR).
So the new version of the plugin still works with the old files, not the new ones.
So the new version of the plugin still works with the old files, not the new ones.
The FDA approved Citius Pharma's new immunotherapy for adults with cutaneous T-cell lymphoma, a type of non-Hodgkin's lymphoma that primarily affects the skin.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
Citius Pharmaceuticals Receives FDA Approval for LYMPHIR™ (denileukin diftitox-cxdl) Immunotherapy for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
/PRNewswire/ -- Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) ("Citius", "Citius Pharma"), announced today that the U.S. Food and Drug Administration (FDA) has...
www.prnewswire.com
August 8, 2024 at 2:27 PM
The FDA approved Citius Pharma's new immunotherapy for adults with cutaneous T-cell lymphoma, a type of non-Hodgkin's lymphoma that primarily affects the skin.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
#CTOR #CTXR Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-september-2026-investor-932j0502zqoq.html
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-september-2026-investor-932j0502zqoq.html
Citius Pharma CEO to speak at two New York conferences
Citius Pharma CEO Leonard Mazur is scheduled to present Sept. 9 and 15 in New York, with one-on-one meetings and webcasts listed for both events; times may change.
www.stocktitan.net
September 3, 2026 at 12:30 PM
#CTOR #CTXR Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-september-2026-investor-932j0502zqoq.html
https://www.stocktitan.net/news/CTOR/citius-pharmaceuticals-to-participate-in-september-2026-investor-932j0502zqoq.html
Citius Pharmaceuticals (NASDAQ: CTXR) reports $5.6M in LYMPHIR net revenue in its first six months of commercial sales, with ~80% gross margins and nearly 100% payer coverage. A deep pipeline adds further upside. #Oncology #Biopharma
August 27, 2026 at 8:23 AM
Citius Pharmaceuticals (NASDAQ: CTXR) reports $5.6M in LYMPHIR net revenue in its first six months of commercial sales, with ~80% gross margins and nearly 100% payer coverage. A deep pipeline adds further upside. #Oncology #Biopharma
🚨 $CTXR
On August 17, 2026, Citius Pharmaceuticals, Inc. received formal notice that the Nasdaq Stock Market LLC granted our request for an extension through February 8, 2027 to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant ...
On August 17, 2026, Citius Pharmaceuticals, Inc. received formal notice that the Nasdaq Stock Market LLC granted our request for an extension through February 8, 2027 to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant ...
SEC Filing: CTXR
Click to view the official SEC document.
www.sec.gov
August 21, 2026 at 8:42 PM
🚨 $CTXR
On August 17, 2026, Citius Pharmaceuticals, Inc. received formal notice that the Nasdaq Stock Market LLC granted our request for an extension through February 8, 2027 to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant ...
On August 17, 2026, Citius Pharmaceuticals, Inc. received formal notice that the Nasdaq Stock Market LLC granted our request for an extension through February 8, 2027 to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant ...
📊 Stock movers right now:
CTXR: $0.56 (-25.6%)
BTAI: $0.89 (-25.2%)
CUE: $27.64 (-19.2%)
BYSI: $0.71 (-15.2%)
SWMR: $47.08 (+13.2%)
More: https://suggestionbox.live/planet-markets
CTXR: $0.56 (-25.6%)
BTAI: $0.89 (-25.2%)
CUE: $27.64 (-19.2%)
BYSI: $0.71 (-15.2%)
SWMR: $47.08 (+13.2%)
More: https://suggestionbox.live/planet-markets
August 18, 2026 at 7:00 AM
📊 Stock movers right now:
CTXR: $0.56 (-25.6%)
BTAI: $0.89 (-25.2%)
CUE: $27.64 (-19.2%)
BYSI: $0.71 (-15.2%)
SWMR: $47.08 (+13.2%)
More: https://suggestionbox.live/planet-markets
CTXR: $0.56 (-25.6%)
BTAI: $0.89 (-25.2%)
CUE: $27.64 (-19.2%)
BYSI: $0.71 (-15.2%)
SWMR: $47.08 (+13.2%)
More: https://suggestionbox.live/planet-markets
Citius Pharmaceuticals (CTXR) Q3 Results, LYMPHIR Demand www.stocks2buy.net/newsitems/ci...
Citius Pharmaceuticals (CTXR) Q3 Results, LYMPHIR Demand
Citius Pharmaceuticals (NASDAQ: CTXR) Reports Fiscal Q3 Results as LYMPHIR Demand Builds
www.stocks2buy.net
August 17, 2026 at 5:16 PM
Citius Pharmaceuticals (CTXR) Q3 Results, LYMPHIR Demand www.stocks2buy.net/newsitems/ci...
$AMLX to share Phase 3 LUCIDITY study data on avexitide for post-bariatric hypoglycemia Aug 18, 2026; webcast at 8am ET. $EYPT $ADIL $CUE $CTXR $ARGX $FDMT $GLMD $BTAI $SKYE
www.biopharmcatalyst.com/news/2026/ad...
www.biopharmcatalyst.com/news/2026/ad...
Daily Updates 08/17/26
export-download.canva.com
August 17, 2026 at 8:30 PM
$AMLX to share Phase 3 LUCIDITY study data on avexitide for post-bariatric hypoglycemia Aug 18, 2026; webcast at 8am ET. $EYPT $ADIL $CUE $CTXR $ARGX $FDMT $GLMD $BTAI $SKYE
www.biopharmcatalyst.com/news/2026/ad...
www.biopharmcatalyst.com/news/2026/ad...
🚨 $CTXR
On August 14, 2026, Citius Pharmaceuticals, Inc. issued a press release announcing its results of operations for the third quarter of fiscal 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
On August 14, 2026, Citius Pharmaceuticals, Inc. issued a press release announcing its results of operations for the third quarter of fiscal 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
SEC Filing: CTXR
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 8:54 PM
🚨 $CTXR
On August 14, 2026, Citius Pharmaceuticals, Inc. issued a press release announcing its results of operations for the third quarter of fiscal 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
On August 14, 2026, Citius Pharmaceuticals, Inc. issued a press release announcing its results of operations for the third quarter of fiscal 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.